Robust R&D Pipeline: AstraZeneca consistently invests heavily in research and development, particularly in high-growth areas like oncology, rare diseases, and CVRM, ensuring a steady stream of innovative drugs and future revenue drivers.

Global Market Presence: With operations and sales teams spanning numerous countries, AstraZeneca possesses a vast geographic footprint, enabling diversified revenue streams and access to diverse patient populations and healthcare markets worldwide.

Diversified Product Portfolio: The company boasts a broad array of approved medications across multiple therapeutic areas, significantly reducing reliance on any single drug and providing resilience against market shifts or patent expirations.